Aladdin Healthcare Technologies SE
NMI
Aladdin Healthcare Technologies SE, alongside its subsidiary Aladdin Healthcare... Aladdin Healthcare Technologies SE, alongside its subsidiary Aladdin Healthcare Technologies Ltd, crafts software platforms for the secure safeguarding and efficient organization of medical data, primarily utilizing blockchain technology. The company exhibits profound expertise in cutting-edge domains such as blockchain, machine learning, and artificial intelligence. Its advanced offerings include an AI-driven platform for early diagnosis through sophisticated brain imaging analysis, a Health Risk Assessment platform designed to gauge patient susceptibility to cardiovascular, diabetic, and renal conditions, and an AI-powered Drug Discovery platform. This latter tool is instrumental in identifying small molecule compounds effective against various age-related ailments like Alzheimer's and Parkinson's diseases, as well as SARS-CoV-2. Employing a synergistic blend of blockchain, machine learning, artificial intelligence, and sophisticated predictive data analytics, Aladdin Healthcare Technologies focuses on the proactive detection of chronic illnesses. Established in 2014, its operations are based in Berlin, Germany.
